Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Aug;458(4):713-21.
doi: 10.1007/s00424-009-0660-4. Epub 2009 Mar 31.

AMPK controls epithelial Na(+) channels through Nedd4-2 and causes an epithelial phenotype when mutated

Affiliations

AMPK controls epithelial Na(+) channels through Nedd4-2 and causes an epithelial phenotype when mutated

Joana Almaça et al. Pflugers Arch. 2009 Aug.

Erratum in

  • Pflugers Arch. 2010 Nov;460(6):1105-6

Abstract

The metabolic sensor adenosine-monophosphate-activated kinase (AMPK) detects the cellular energy status and adjusts metabolic activity according to the cytosolic AMP to ATP ratio. Na(+) absorption by epithelial Na(+) channels (ENaC) is a highly energy-consuming process that is inhibited by AMPK. We show that the catalytic subunit alpha1 of AMPK inhibits ENaC in epithelial tissues from airways, kidney, and colon and that AMPK regulation of ENaC is absent in AMPKalpha1-/- mice. These mice demonstrate enhanced electrogenic Na(+) absorption that leads to subtle changes in intestinal and renal function and may also affect Na(+) absorption and mucociliary clearance in the airways. We demonstrate that AMPK uses the ubiquitin ligase Nedd4-2 to inhibit ENaC by increasing ubiquitination and endocytosis of ENaC. Thus, enhanced expression of epithelial Na(+) channels was detected in colon, airways, and kidney of AMPKalpha1-/- mice. Therefore, AMPKalpha1 is a physiologically important regulator of electrogenic Na(+) absorption and may provide a novel pharmacological target for controlling epithelial Na(+) transport.

PubMed Disclaimer

References

    1. Annu Rev Physiol. 2009;71:361-79 - PubMed
    1. Dev Cell. 2006 Jun;10(6):839-50 - PubMed
    1. J Clin Invest. 2001 Oct;108(8):1167-74 - PubMed
    1. Eur J Immunol. 2008 Apr;38(4):948-56 - PubMed
    1. Eur J Biochem. 1997 Jun 1;246(2):259-73 - PubMed

Publication types

Substances

LinkOut - more resources